Skip to main content
. 2017 Mar 4;8(25):41631–41640. doi: 10.18632/oncotarget.15892

Figure 3.

Figure 3

Kaplan-Meier curves for PFS1 (A) and PFS2 (B) in patients who had extensive/rapid disease progression versus those with local/slow progression.